The incidence of prenatal alcohol exposure in montevideo uruguay as determined by meconium analysis

Therapeutic Drug Monitoring

Volumn 32, Issue 3, 2010, Pages 311-317

  Hutson, Janine R ^a,b   Magri, Raquel ^c   Gareri, Joey N ^a   Koren, Gideon ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Centro Hospitalario Pereira Rossell   (Uruguay)

Author keywords

Biomarker; Fatty acid ethyl esters; Fetal alcohol syndrome; Meconium; Population health; Uruguay

Indexed keywords

ALCOHOL; FATTY ACID ESTER; ILLICIT DRUG; LINOLEIC ACID ETHYL ESTER;

ADULT; ALCOHOL INTOXICATION; BIRTH WEIGHT; BODY MASS; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG ABUSE; FEMALE; FETUS RISK; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MECONIUM; MOTHER; NEWBORN; PREDICTION; PRENATAL EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX; SMOKING; URUGUAY;

ALCOHOL DRINKING; ETHANOL; FEMALE; FETAL ALCOHOL SYNDROME; HUMANS; INCIDENCE; INFANT, NEWBORN; MECONIUM; PREGNANCY; URUGUAY;

EID: 77952951145     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3181dda52a     Document Type: Conference Paper

References (40)

1. Croxford J, Viljoen D. Alcohol consumption by pregnant women in the Western Cape. S Afr Med J. 1999;89:962-965.
2. May PA, Gossage JP, Marais AS, et al. The epidemiology of fetal alcohol syndrome and partial FAS in a South African community. Drug Alcohol Depend. 2007;88:259-271.
3. Garcia-Algar O, Kulaga V, Gareri J, et al. Alarming prevalence of fetal alcohol exposure in a Mediterranean city. Ther Drug Monit. 2008;30: 249-254
4. Ḿguez H. La Alcoholización Juvenil en la Argentina. Acta Psiquiát Psicol América. 2004;50:43-47.
5. Magri R. Gender, Alcohol and Culture: an International Study. Montevideo, Uruguay: GENACIS, PAHO/WHO; 2004.
6. Junta Nacional de Drogas, 2001. Tercera encuesta nacional en hogares sobre consumo de drogas en población general. Available at: www.info-drogas.gub.uy. Accessed April 2007.
7. Pepino MY, Mennella JA. Advice given to women in Argentina about breast-feeding and the use of alcohol. Rev Panam Salud Publica. 2004;16: 408-414.
8. Briozzo L, Vidiella G, Rodriguez F, et al. A risk reduction strategy to prevent maternal deaths associated with unsafe abortion. Int J Gynaecol Obstet. 2006;95:221-226.
9. Abel EL, Hannigan JH. Maternal risk factors in fetal alcohol syndrome: provocative and permissive influences. Neurotoxicol Teratol. 1995;17: 445-462.
10. SistemaInformáticoPerinatal. Montevideo, Uruguay: Publicacióncient́?f-ica del CLAP; 2001.
11. Besculides M, Laraque F. Unintended pregnancy among the urban poor. J Urban Health. 2004;81:340-348.
12. Derauf C, Katz AR, Frank DA, et al. The prevalence of methamphetamine and other drug use during pregnancy in Hawaii. J Drug Issues. 2003;33: 1001-1016.
13. Gareri J, Lynn H, Handley M, et al. Prevalence of fetal ethanol exposure in a regional population-based sample by meconium analysis of fatty acid ethyl esters. Ther Drug Monit. 2008;30:239-245.
14. Chan D, Bar-Oz B, Pellerin B, et al. Population baseline of meconium fatty acid ethyl esters among infants of nondrinking women in Jerusalem and Toronto. Ther Drug Monit. 2003;25:271-278.
15. Bar-Oz B, Klein J, Karaskov T, Koren G. Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse. Arch Dis Child Fetal Neonatal Ed. 2003;88:F98-F100.
16. Dempsey D, Moore C, Deitermann D, et al. The detection of cotinine in hydrolyzed meconium samples. Forensic Sci Int. 1999;102:167-171.
17. Cotinine Direct ELISA Kit (package insert). Pomona, CA: Immunalysis Corporation; January 2004.
18. Kramer MS. Determinants of low birth weight: methodological assessment and meta-analysis. Bull World Health Organ. 1987;65: 663-737.
19. Jewell RT, Triunfo P. The impact of prenatal care on birthweight: the case of Uruguay. Health Econ. 2006;15:1245-1250.
20. May PA, Gossage JP, Brooke LE, et al. Maternal risk factors for fetal alcohol syndrome in the Western Cape Province of South Africa: a population-based study. Am J Public Health. 2005;95:1190-1199.
21. May PA, Gossage JP, White-Country M, et al. Alcohol consumption and other maternal risk factors for fetal alcohol syndrome among three distinct samples of women before, during, and after pregnancy: the risk is relative. Am J Med Genet C Semin Med Genet. 2004;127:10-20.
22. Derauf C, Katz AR, Easa D. Agreement between maternal self-reported ethanol intake and tobacco use during pregnancy and meconium assays for fatty acid ethyl esters and cotinine. Am J Epidemiol. 2003;158:705-709.
23. Russell M, Martier SS, Sokol RJ, et al. Detecting risk drinking during pregnancy: a comparison of four screening questionnaires. Am J Public Health. 1996;86:1435-1439.
24. Bradley KA, Boyd-Wickizer J, Powell SH, et al. Alcohol screening questionnaires in women: a critical review. JAMA. 1998;280:166-171.
25. Caballero Martinez L, Caballero Martinez F, Santodomingo Carrasco J. Instrumentos de deteccion de alcoholismo: precisiones sobre el cuestionario CAGE. Med Clin (Barc). 1988;91:515.
26. Bearer CF, Lee S, Salvator AE, et al. Ethyl linoleate in meconium: a biomarker for prenatal ethanol exposure. Alcohol Clin Exp Res. 1999;23:487-493.
27. Bearer CF, Jacobson JL, Jacobson SW, et al. Validation of a new biomarker of fetal exposure to alcohol. J Pediatr. 2003;143:463-469.
28. Pereg D, Lagueux J, Dewailly E, et al. Cigarette smoking during pregnancy: comparison of biomarkers for inclusion in epidemiological studies. Biomarkers. 2001;6:161-173.
29. Ostrea EM Jr, Knapp DK, Romero A, et al. Meconium analysis to assess fetal exposure to nicotine by active and passive maternal smoking. J Pediatr. 1994;124:471-476.
30. Sherif NA, Kamel SM, Al-Ashkar OS, et al. Detection of cotinine in neonate meconium as a marker for nicotine exposure in utero. La Revue de Santé de la Méditerranéeorientale. 2004;10:96-105.
31. Koren G. Maternal-Fetal Toxicology: a Clinician's Guide, 3rd ed. New York: Marcel Dekker, Inc; 2001:458.
32. Ho E, Karimi-Tabesh L, Koren G. Characteristics of pregnant women who use ecstasy (3, 4-methylenedioxymethamphetamine). Neurotoxicol Teratol. 2001;23:561-567.
33. Sprauve ME, Lindsay MK, Drews-Botsch CD, et al. Racial patterns in the effects of tobacco use on fetal growth. Am J Obstet Gynecol. 1999;181: S22-S27.
34. Mariscal M, Palma S, Llorca J, et al. Pattern of alcohol consumption during pregnancy and risk for low birth weight. Ann Epidemiol. 2006;16:432-438.
35. Ostrea EM Jr. Understanding drug testing in the neonate and the role of meconium analysis. J Perinat Neonatal Nurs. 2001;14: 61-82.
36. Mirochnick M, Frank DA, Cabral H, et al. Relation between meconium concentration of the cocaine metabolite benzoylecgonine and fetal growth. J Pediatr. 1995;126:636-638.
37. Delaney-Black V, Covington C, Ostrea E Jr, et al. Prenatal cocaine and neonatal outcome: evaluation of dose-response relationship. Pediatrics. 1996;98:735-740.
38. Little BB, Snell LM, Gilstrap LD 3rd, et al. Patterns of multiple substance abuse during pregnancy: implications for mother and fetus. South Med J. 1990;83:507-509.
39. Jacob J, Harrison H Jr, Tigert AT. Prevalence of alcohol and illicit drug use by expectant mothers. Alaska Med. 1995;37:83-87.
40. Church MW, Holmes PA, Overbeck GW, et al. Interactive effects of prenatal alcohol and cocaine exposures on postnatal mortality, development and behavior in the Long-Evans rat. Neurotoxicol Teratol. 1991;13:377-386.